Impact of Eccentric Training in Hypoxia With Creatine on Metabolic Control and VO2max in Patients With Type 1 Diabetes - Trial NCT06345612
Access comprehensive clinical trial information for NCT06345612 through Pure Global AI's free database. This phase not specified trial is sponsored by Silesian Centre for Heart Diseases and is currently Recruiting. The study focuses on Type 1 Diabetes. Target enrollment is 28 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Silesian Centre for Heart Diseases
Timeline & Enrollment
N/A
Nov 15, 2023
Jul 01, 2025
Primary Outcome
Metabolic control of diabetes,Time in range,Time below range,Maximum oxygen consumption (VO2max)
Summary
Exercise plays an important role in treatment of diabetes. In recent years exercise training
 in normobaric hypoxia is used in training programs for athletes and in rehabilitation and
 also commercially. The aim of the study is to assess the impact of eccentric training
 conducted in conditions of normobaric hypoxia or normoxia and creatine supplementation on
 metabolic control: profile and stability of glucose concentration, HbA1c value, hypoglycemia
 and insulin demand, as well as the level of muscle strength, VO2max and anthropometric
 parameters
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06345612
Non-Device Trial